Abstract
With the development of anti-HBV and HCV therapy, experts in related fields organized by the Liver Cancer Study Group, Chinese Society of Hepatology, Chinese Medical Association updated "Experts Consensus on Antiviral Therapy for HBV/ HCV-related Hepatocellular Carcinoma" . On the basis of previous expert recommendations/consensus and the new evidence in recent years, this new consensus was developed, and the relevant recommendations are provided to hepatologists, epidemiologists, medical doctors and specialists working in community service centers and primary health care institutions for guidance of hepatocellular carcinoma antiviral treatment.